M Suffness
Impact in
- Biomaterials top 5%
- Nanoparticle-Based Drug Delivery
- Molecular Biology top 10%
- Phytochemical Studies and Bioactivities
- Phytochemical compounds biological activities
- Biological Activity of Diterpenoids and Biflavonoids
Papers in
- Oncology 7
- Cancer Treatment and Pharmacology 6
-
- Alkaloids: synthesis and pharmacology 2
- Microbial Natural Products and Biosynthesis 2
- Berberine and alkaloids research 2
- Co-authors
- Jerry L. McLaughlin (1 shared paper)Jake E. Anderson (1 shared paper)Frances D. Gillin (1 shared paper)David S. Reiner (1 shared paper)Jan A. Gliński (1 shared paper)Ven L. Narayanan (1 shared paper)Leon H. Zalkow (1 shared paper)Rudiger D. Haugwitz (1 shared paper)
- Journals
- Journal of Clinical Oncology (2 papers)Antimicrobial Agents and Chemotherapy (2 papers)Recent results in cancer research (1 paper)Journal of the American Chemical Society (1 paper)Journal of Medicinal Chemistry (1 paper)
- Partner nations
- United StatesUnited Kingdom
In The Last Decade
M Suffness
18 papers receiving 1.7k citations
Peers
Comparison fields: 5 of 86
- Biomaterials 160
- Molecular Biology 730
- Plant Science 441
- Oncology 227
- Pharmaceutical Science 58
Countries citing papers authored by M Suffness
This map shows the geographic impact of M Suffness's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M Suffness with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M Suffness more than expected).
Fields of papers citing papers by M Suffness
This network shows the impact of papers produced by M Suffness. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M Suffness. The network helps show where M Suffness may publish in the future.
Co-authors
The 25 scholars most cited alongside M Suffness, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Assays related to cancer drug discovery | 1990 | 435 |
| 2 | Taxol®: science and applications. | 1995 | 320 |
| 3 | 1991 | 220 | |
| 4 | 1989 | 204 | |
| 5 | A reassessment of cardiac toxicity associated with Taxol. | 1993 | 152 |
| 6 | 1982 | 115 | |
| 7 | 1986 | 74 | |
| 8 | Clinical development of Taxol. | 1993 | 52 |
| 9 | Antitumor activity and biochemical effects of aphidicolin glycinate (NSC 303812) alone and in combination with cisplatin in vivo. | 1994 | 47 |
| 10 | 1987 | 37 | |
| 11 | 1988 | 33 | |
| 12 | 1968 | 31 | |
| 13 | 1986 | 31 | |
| 14 | 1981 | 28 | |
| 15 | 1995 | 17 | |
| 16 | Is taxol a surrogate for a universal regulator of mitosis? | 1995 | 16 |
| 17 | Indicine N-oxide: clinical use of a pyrrolizidine alkaloid. | 1987 | 6 |
| 18 | 1986 | 2 | |
| 19 | Stability of the in vivo P388 leukemia model in evaluation of antitumor activity of natural products. | 1985 | 1 |
About M Suffness
M Suffness is a scholar working on Oncology, Pharmacology, Molecular Biology, Toxicology and Small Animals, having authored 19 papers that have together received 1.8k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (6 papers), Cancer therapeutics and mechanisms (3 papers), Phytochemical compounds biological activities (3 papers), Alkaloids: synthesis and pharmacology (2 papers), Bioactive Compounds and Antitumor Agents (2 papers), Microbial Natural Products and Biosynthesis (2 papers), Berberine and alkaloids research (2 papers) and Animal testing and alternatives (2 papers). The work is most often cited by research in Biomaterials (160 citations), Molecular Biology (730 citations), Plant Science (441 citations), Oncology (227 citations) and Pharmaceutical Science (58 citations). M Suffness has collaborated with scholars based in United States and United Kingdom. Frequent co-authors include Jerry L. McLaughlin, Jake E. Anderson, Frances D. Gillin, David S. Reiner, Jan A. Gliński, Ven L. Narayanan, Leon H. Zalkow, Rudiger D. Haugwitz, Howard M. Deutsch and Susan G. Arbuck. Their work appears in journals such as Journal of Clinical Oncology, Antimicrobial Agents and Chemotherapy, Recent results in cancer research, Journal of the American Chemical Society and Journal of Medicinal Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.